Comparative study of the in situ immune response in oral and nasal mucosal leishmaniasis

Parasite Immunology

Volumn 34, Issue 1, 2012, Pages 23-31

  Palmeiro, M R ^a,b   Morgado, F N ^a,b   Valete Rosalino, C M ^b,c   Martins, A C ^b   Moreira, J ^b   Quintella, L P ^b   de Oliveira Schubach, A ^b   Conceicao Silva F ^a  

^a INSTITUTO OSWALDO CRUZ   (Brazil)

^b Funda??o Oswaldo Cruz   (Brazil)

^c FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

Author keywords

American tegumentary leishmaniasis; Immunohistochemistry; Inflammation; Leishmania; Mucosal leishmaniasis; Oral lesions

Indexed keywords

CD22 ANTIGEN; CD3 ANTIGEN; CD4 ANTIGEN; CHLORDANE; FAS LIGAND; INDUCIBLE NITRIC OXIDE SYNTHASE; KI 67 ANTIGEN; LEUKOCYTE ELASTASE; PROTEIN BCL 2; T6 ANTIGEN;

ADULT; AGED; ARTICLE; CELL COUNT; CELL PROLIFERATION; CLINICAL ARTICLE; COMPARATIVE STUDY; DONOR; EATING DISORDER; FEMALE; GINGIVITIS; HUMAN; HUMAN TISSUE; IMMUNE RESPONSE; IMMUNOHISTOCHEMISTRY; INFLAMMATION; MACROPHAGE; MALE; MOUTH CAVITY; MOUTH LESION; PARASITE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SKIN LEISHMANIASIS; STIGMA; SYMPTOM; T LYMPHOCYTE; TISSUE INJURY; TOOTH; VISCERAL LEISHMANIASIS;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; IMMUNOLOGIC FACTORS; INFLAMMATION; LEISHMANIASIS; MACROPHAGES; MALE; MICROSCOPY; MIDDLE AGED; MOUTH MUCOSA; NASAL MUCOSA; T-LYMPHOCYTES;

EID: 83655197349     PISSN: 01419838     EISSN: 13653024     Source Type: Journal    
DOI: 10.1111/j.1365-3024.2011.01343.x     Document Type: Article

References (45)

1. Schubach A, Haddad F, Oliveira-Neto MP, et al. Detection of Leishmania DNA polymerase chain reaction in scars of treated human patients. J Infect Dis 1998; 178: 911-914.
2. Lessa MM, Lessa HA, Castro TW, et al. Mucosal leishmaniasis: epidemiological and clinical aspects. Braz J Otorhinolaryngol 2007; 73: 843-847.
3. Marsden PD. Mucosal leishmaniasis ("espundia" Escomel, 1911). Trans R Soc Trop Med Hyg 1986; 80: 859-876.
4. Palmeiro MR, Rosalino CM, Quintella LP, et al. Gingival leishmaniasis in an HIV-negative patient. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2007; 104: e12-e16.
5. Carvalho EM, Johnson WD, Barreto E, et al. Cell mediated immunity in American cutaneous and mucosal leishmaniasis. J Immunol 1985; 135: 4144-4148.
6. Amato VS, de Andrade HF & Duarte MI. Mucosal leishmaniasis: in situ characterization of the host inflammatory response, before and after treatment. Acta Trop 2003; 85: 39-49.
7. Castés M, Agnelli A, Verde O & Rondón AJ. Characterization of the cellular immune response in American cutaneous leishmaniasis. Clin Immunol Immunopathol 1983; 27: 176-178.
8. Martínez-Arends A, Tapla FJ, Cáceres-Dittmar G, Mosca W, Valecillos L & Convit J. Immunocytochemical characterization of immune cells in lesions of american cutaneous leishmaniasis using novel T cell markers. Acta Trop 1991; 49: 271-280.
9. Tuon FF, Gomes-Silva A, Da-Cruz AM, Duarte MI, Neto VA & Amato VS. Local immunological factors associated with recurrence of mucosal leishmaniasis. Clin Immunol 2008; 128: 442-446.
10. Esterre P, Dedet JP, Frenay C, Chevallier M & Grimaud JA. Cell populations in the lesion of human cutaneous leishmaniasis: a light microscopical, immunohistochemical and ultrastructural study. Virchows Arch A Pathol Anat Histopathol 1992; 421: 239-247.
11. Boaventura VS, Santos CS, Cardoso CR, et al. Human mucosal leishmaniasis: neutrophils infiltrate areas of tissue damage that express high levels of Th-17-related cytokines. Eur J Immunol 2010; 40: 2830-2836.
12. Barral A, Jesus AR, Almeida RP, et al. Evaluation of T-cell subsets in the lesions infiltrates of human cutaneous and mucocutaneous leishmaniasis. Parasite Immunol 1987; 9: 487-497.
13. Faria DR, Gollob KJ, Barbosa J Jr, et al. Decreased in situ expression of interleukin-10 receptor is correlated with the exacerbated inflammatory and cytotoxic responses observed in mucosal leishmaniasis. Infect Immunol 2005; 73: 7853-7859.
14. Morgado FN, Schubach A, Rosalino CMV, et al. Is the in situ inflammatory reaction an important tool to understand the cellular immune response in American tegumentary leishmaniasis? Br J Dermatol 2008; 158: 50-58.
15. Morgado FN, Schubach A, Vasconcellos E, et al. Signs of an in situ inflammatory reaction in scars of human American tegumentary leishmaniasis. Parasite Immunol 2010; 32: 285-295.
16. Modlin RL, Tapia FJ, Bloom BR, et al. In situ characterization of the cellular immune response in American cutaneous leishmaniasis. Clin Exp Immunol 1985; 60: 241-248.
17. Barral-Netto M, Barral A, Brodskyn C, Carvalho EM & Reed SG. Cytotoxicity in human mucosal and cutaneous leishmaniasis. Parasite Immunol 1995; 17: 21-28.
18. Neworal EP, Altemani A, Mamoni RL, Noronha IL & Blotta MH. Immunocytochemical localization of cytokines and inducible nitric oxide synthase (iNOS) in oral mucosal and lymph node of patients with paracoccidioidomycosis. Cytokine 2003; 21: 234-241.
19. Yamazaki K, Nakajima T & Hara K. Immunohistological analysis of T cell functional subsets in chronic inflammatory periodontal disease. Clin Exp Immunol 1995; 99: 384-391.
20. Lappin DF, Koulouri O, Radvar M, Hodge P & Kinane DF. Relative proportions of mononuclear cell types in periodontal lesions analyzed by immunohistochemistry. J Clin Periodontol 1999; 26: 183-189.
21. Greves G, Klemens A, Menauer F & Sturm C. Involvement of inferior turbinate mucosa in chronic sinusitis-localization of T-cell subset. Allergy 2000; 55: 1155-1162.
22. Petit MD, Hovenkamp E, Hamann D, et al. Phenotypical and functional analysis of T cells in periodontitis. J Periodontol Res 2001; 36: 214-220.
23. Walton LJ, Thornill MH, Macey MG & Farthing PM. Cutaneous lymphocyte associated antigen (CLA) and alpha e beta 7 integrins are expressed by mononuclear cells in skin and oral lichen planus. J Oral Pathol Med 1997; 26: 402-407.
24. Lourenço SV, de Carvalho FR, Boggio P, et al. Lupus erythematosus: clinical and histopathological study of oral manifestations and immunohistochemical profile of the inflammatory infiltrate. J Cutan Pathol 2007; 34: 558-564.
25. Kendall HK, Marshall RI & Bartold PM. Nitric oxide and tissue destruction. Oral Dis 2001; 7: 2-10.
26. Kharitnonov SA, Rajakulasingam K, O'Connor B, Durham SR & Barnes PJ. Nasal nitric oxide is increased in patients with asthma and allergic rhinitis and may be modulated by nasal glucocorticoids. J Allergy Clin Immunol 1997; 99: 58-64.
27. Ribeiro-Gomes FL, Otero AC, Gomes NA, et al. Macrophage interactions with neutrophils regulate Leishmania major infection. J Immunol 1987; 9: 487-497.
28. Lima GM, Vallochi AL, Silva UR, Bevilacqua EM, Kiffer MM & Abrahamsohn IA. The role of polymorphonuclear leucocytes in the resistance to cutaneous leishmaniasis. Immunol Lett 1998; 64: 145-151.
29. Guimarães-Costa AB, Nascimento MT, Froment GS, et al. Leishmania amazonensis promastigotes induce and are killed by neutrophil extracellular traps. Proc Natl Acad Sci U S A 2009; 106: 6748-6753.
30. Murphy GF. Cell membrane glycoproteins and Langerhans cells. Hum Pathol 1985; 16: 103-112.
31. Zavala WD & Cavicchia JC. Deterioration of the Langerhans cell network of the human gingival epithelium with aging. Arch Oral Biol 2006; 51: 1150-1155.
32. Hellquist HB, Olsen KE, Irander K, Karlsson E & Odkvist LM. Langerhans cells and subsets of lymphocytes in the nasal mucosa. APMIS 1991; 99: 449-454.
33. El-Hassan AM, Gaafar A & Theander TG. Antigen-presenting cells in human cutaneous leishmaniasis due to Leishmania major. Clin Exp Immunol 1995; 99: 445-453.
34. Kaminagakura E, Bonan PR, Lopes MA & Almeida OP. Cell proliferation and P53 expression in pseudoepitheliomatous hyperplasia of oral paracoccidioidomycosis. Mycoses 2006; 49: 393-403.
35. Cruchley AT, De Souza YG, Williams DM, Greenspan D & Greenspan JS. Bromodeoxyuridine incorporation and Ki67 expression in oral hairy leukoplakia. Oral Dis 1998; 4: 9-15.
36. Mcalinden RL, Maxwell P, Napier S, et al. Bcl-2 expression in sequential biopsies of potentially malignant oral mucosal lesions assessed by immunocytochemistry. Oral Dis 2000; 6: 318-326.
37. Loro LL, Johannessen AC & Vintermyr OK. Decreased expression of Bcl-2 in moderate and severe oral epithelia dysplasias. Oral Oncol 2002; 38: 691-698.
38. Guan DW, Ohshima T & Kondo T. Immunohistochemical study on Fas and Fas ligand in skin wound healing. Histochemical J 2000; 32: 85-91.
39. Meger M, Viney JL, Borojevic R, et al. Defining the roles of perforin, Fas/FasL, and tumour necrosis factor a in T cell induced mucosal damage in the mouse intestine. Gut 2002; 1: 155-163.
40. Zhu Q, Liu JY, Xu HW, et al. Mechanism of counterattack of colorectal cancer cell by Fas/Fas ligand system. World J Gastroenterol 2005; 11: 6125-6129.
41. Souza HS, Neves MS, Elia CC, et al. Distinct patterns of mucosal apoptosis in H pylori-associated gastric ulcerate associated with altered FASL and perforin cytotoxic pathways. World J Gastroenterol 2006; 12: 6133-6141.
42. Loro LL, Vintermyr OK, Johannessen AC, Liavaag PG & Jonsson R. Suppression of Fas receptor and negative correlation of Fas ligand with differentiation and apoptosis in oral squamous cell carcinoma. J Oral Pathol Med 1999; 28: 82-87.
43. Campanelli AP, Martins GA, Souto JT, et al. Fas-Fas Ligand (CD95-CD95L) and cytotoxic T Lymphocyte antigen-4 engagement mediate T cell unresponsiveness in patients with paracoccidioidomycosis. J Infect Dis 2003; 187: 1496-1505.
44. Conceição-Silva F, Hahne M, Schröter M, Louis J & Tschopp J. The resolution of lesions induced by Leishmania major in mice requires a functional Fas (APO-1, CD95) pathway of cytotoxicity. Eur J Immunol 1998; 28: 237-245.
45. Quintella LP, Cuzzi T, Madeira MF, Okamoto T & Schubach AO. Immunoperoxidase technique using an anti-Leishmania (L.) chagasi hyperimmune serum in the diagnosis of culture-confirmed American tegumentary leishmaniasis. Rev Inst Med Trop Sao Paulo 2009; 51: 83-86.